Literature DB >> 29976459

Alzheimer's disease research: the future of BACE inhibitors.

Talha Burki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29976459     DOI： 10.1016/S0140-6736(18)31425-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Therapeutic Approach to Alzheimer's Disease: Current Treatments and New Perspectives.

Authors:  Teresa Pardo-Moreno; Anabel González-Acedo; Antonio Rivas-Domínguez; Victoria García-Morales; Francisco Jose García-Cozar; Juan Jose Ramos-Rodríguez; Lucía Melguizo-Rodríguez
Journal:  Pharmaceutics       Date:  2022-05-24       Impact factor: 6.525

Review 2.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

3.  Performance evaluation of molecular docking and free energy calculations protocols using the D3R Grand Challenge 4 dataset.

Authors:  Eddy Elisée; Vytautas Gapsys; Nawel Mele; Ludovic Chaput; Edithe Selwa; Bert L de Groot; Bogdan I Iorga
Journal:  J Comput Aided Mol Des       Date:  2019-11-01       Impact factor: 3.686

4.  Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation.

Authors:  Matthias Brendel; Anna Jaworska; Felix Overhoff; Tanja Blume; Federico Probst; Franz-Josef Gildehaus; Peter Bartenstein; Christian Haass; Bernd Bohrmann; Jochen Herms; Michael Willem; Axel Rominger
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

Review 5.  Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?

Authors:  Yuan Dong; Xiaoheng Li; Jinbo Cheng; Lin Hou
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

6.  Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer's Disease.

Authors:  Gwendolyn E Kaeser; Jerold Chun
Journal:  Front Genet       Date:  2020-05-07       Impact factor: 4.599

Review 7.  Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease.

Authors:  Kenjiro Ono; Mayumi Tsuji
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  The Tripeptide RER Mimics Secreted Amyloid Precursor Protein-Alpha in Upregulating LTP.

Authors:  Jodi A Morrissey; Erin Bigus; Julie C Necarsulmer; Vinay Srinivasan; Katie Peppercorn; Daniel J O'Leary; Bruce G Mockett; Warren P Tate; Stephanie M Hughes; Karen D Parfitt; Wickliffe C Abraham
Journal:  Front Cell Neurosci       Date:  2019-10-18       Impact factor: 5.505

Review 9.  Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease.

Authors:  Teeba Athar; K Al Balushi; Shah Alam Khan
Journal:  Mol Biol Rep       Date:  2021-06-28       Impact factor: 2.316

Review 10.  Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches.

Authors:  Kiran Kumar Siddappaji; Shubha Gopal
Journal:  AIMS Neurosci       Date:  2021-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.